KANTAR HEALTH BLOG

To better understand the characteristics of statin users in South Korea, we investigated the prevalence of comorbidities and the burden of healthcare resource utilization using 5 years of Health Insurance Review and Assessment-National Patients Sample (HIRA-NPS) data.

Co-authored by Stephanie Hawthorne

Co-authored by Stephanie Hawthorne

Treatment of CLL just became even more chemo free as Imbruvica in combination with Rituxan was shown to be more effective than FCR, the standard chemoimmunotherapy for young, fit patients without TP53 mutated / del17p high-risk disease.

Monumental advances continue in AML with the latest data from ASH 2018 for the newest approvals in unfit AML.